Publications
Talbot A, Li K, Lee JHJ, Lang S, Liu C, Kalter N, Li Z, Mortazavi Y, Almudhfar N, Muldoon JJ, Allain V, Nyberg W, Chung JJ, Wang C, Qi Z, Krishnappa N, Ha AS, Kong D, Houser D, Paruthiyil S, Ahmadi M, Ji Y, Rosenberg M, Acevedo LA, Liang B, Briseno K, Kwek SS, Giannikopoulos P, Rivière I, Sadelain M, Oh DY, Marson A, Hendel A, Martin T, Eyquem J, Shy BR. Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma. bioRxiv : the preprint server for biology. 2026. PMID: 42079140
Talbot A, Li K, Lee JHJ, Lang S, Liu C, Kalter N, Li Z, Mortazavi Y, Almudhfar N, Muldoon JJ, Allain V, Nyberg W, Chung JJ, Wang C, Qi Z, Krishnappa N, Ha AS, Kong D, Houser D, Paruthiyil S, Ahmadi M, Ji Y, Rosenberg M, Acevedo LA, Liang B, Briseno K, Kwek SS, Giannikopoulos P, Rivière I, Sadelain M, Oh DY, Marson A, Hendel A, Martin T, Eyquem J, Shy BR. Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma. bioRxiv : the preprint server for biology. 2026. PMID: 42079140
Chari A, Costello C, Krishnan A, Patel K, Banerjee R, Berdeja JG, Biran N, Callander N, Costa LJ, Dhakal B, Gasparetto C, Hansen DK, Kumar A, Nooka AK, Pan D, Richard S. Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference. American journal of hematology. 2026. PMID: 42014940
Chari A, Costello C, Krishnan A, Patel K, Banerjee R, Berdeja JG, Biran N, Callander N, Costa LJ, Dhakal B, Gasparetto C, Hansen DK, Kumar A, Nooka AK, Pan D, Richard S. Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference. American journal of hematology. 2026. PMID: 42014940
Cheo FF, Farishta A, Garcia BM, Ai WZ, Ganapathi K, Pincus LB. Cutaneous Manifestation of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma: A Clue to A Gastrointestinal Malignancy. Journal of cutaneous pathology. 2026. PMID: 42011981
Denkert C, Rachakonda S, Pehl A, Marmé F, Martin M, Karn T, Untch M, Bonnefoi H, Kim SB, Hirmas N, Bear H, Witkiewicz AK, Im SA, DeMichele A, Veer LV, McCarthy N, Stiewe T, Jank P, Gelmon KA, García-Sáenz JA, Westhoff C, Kelly CM, Reimer T, Olivé MM, Knudsen ES, van Mackelenbergh M, Rojo F, Frickel N, Fasching PA, Teply-Szymanski J, Toi M, Rugo HS, Gnant M, Makris A, Felder B, Nekljudova V, Loibl S. Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial Cohort. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2026. PMID: 42025846
Schlaak M, Cimminiello C, Pigozzo J, Lee J, Grabbe S, Rutkowski P, Mackiewicz J, Tsai KK, Ascierto PA, Mandalà M, Carnevale-Schianca F, Haferkamp S, Atkinson V, Hassel JC, Sandhu S, Sharfman W, Dean E, Noor U, Iyer S, Rabbie R, Ribas A. MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42012456
Rathore U, Dugan E, Thornton H, Kumar VE, Dajani R, Burdick RC, Young JM, Steinhart Z, Lao R, Delviks-Frankenberry KA, Choi W, Henriques WS, Echeverria I, Dann E, Dureja I, Pathak N, Arce MM, McKetney J, Umhoefer JM, Parulekar S, Schmidt R, Polacco BJ, Neidleman J, Montano M, Nguyen VQ, Sali A, Levy JA, Tenthorey JL, Cheng Y, Roan NR, Swaney DL, Kaake RM, Dodgson SE, Hiatt J, Pathak VK, Malik HS, Krogan NJ, Marson A. Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells. Cell. 2026. PMID: 42013838
Puthiyedath R, Dhruva A, Kamal Perera P, Kessler CS. Editorial: The increasing relevance of traditional medicine systems for the primary health care sector and general practice: global research perspectives, volume II. Frontiers in medicine. 2026. PMID: 42136858
Llovet JM, Pinyol R, Affo S, Yarchoan M, Gores GJ, Kelley RK, Lowe SW, Sia D, Villanueva A. Hallmarks of liver cancer: Therapeutic implications. Cell. 2026. PMID: 41997132
Moreno-Rodriguez T, Zhang M, Lundberg A, Shrestha R, Sjöström M, Pasam A, Chan J, Devereux L, Foye A, Zhu X, Weinstein AS, Trigos AS, Wyatt AW, Alumkal JJ, Small EJ, Aggarwal R, Dehm SM, Bootsma ML, Zhao SG, Lupien M, Feng FY, Sandhu S, Quigley DA. Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer. Genome biology. 2026. PMID: 41987223
Moreno-Rodriguez T, Zhang M, Lundberg A, Shrestha R, Sjöström M, Pasam A, Chan J, Devereux L, Foye A, Zhu X, Weinstein AS, Trigos AS, Wyatt AW, Alumkal JJ, Small EJ, Aggarwal R, Dehm SM, Bootsma ML, Zhao SG, Lupien M, Feng FY, Sandhu S, Quigley DA. Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer. Genome biology. 2026. PMID: 41987223
Juric D, Rugo HS, Reising A, Vervier K, Ma C, Ciruelos EM, Loibl S, Singer CF, Sohn J, Campone M, Conte P, Iwata H, Ghaznawi F, Miller M, Taran T, Su F, André F. Genomic Determinants of Response to Alpelisib Plus Fulvestrant in the SOLAR-1 Trial. Annals of oncology : official journal of the European Society for Medical Oncology. 2026. PMID: 41967638
Moradpour M, Moradi Tochayi A, Houshmand S, Nwihim S, Jiang F, Yadav S, Lindsay S, Bergsland EK, Hope TA. Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2026. PMID: 41956562
Sorror ML, Artz AS, Olin RL, Ramlal R, Giralt SA. Eligibility is not appropriateness: Reframing the role of age in allogeneic transplant decision-making. Blood advances. 2026. PMID: 41954617
Kernick C, Chow L, Alejandro M, Li K, Foisey MG, Yang X, Hilburger C, Lu J, Wu L, McClellan A, Takacsi-Nagy O, Brajenovic R, Theberath NE, Fuentes EC, Lin E, Hartman A, Truong T, Lee JHJ, Workley L, Ha AS, Ji Y, Putnam N, Andronikou N, Fatima N, Dotson M, Wong KA, Burns CH, Engelhard FAS, Stoyanova E, Vukovic M, Adie T, Lim WA, Roybal K, Santostefano K, Almeida R, Allen GM, Shy BR, Roth TL. Ultra-large targeted DNA integrations in primary human cells. bioRxiv : the preprint server for biology. 2026. PMID: 41993426
Bhalgat A, Micin K, Affer M, Ayupe AC, Gomez I, Schatz JH, Stelekati E, Williams S, Komanduri K, Wieder E, Cocco E, Taylor J. CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cells. Scientific Reports. 2026. PMID: 41951681
Nguyen DH, Bruck M, Rosenbluth JM. A Shape Analysis Algorithm Quantifies Spatial Morphology and Context of 2D to 3D Cell Culture for Correlating Novel Phenotypes with Treatment Resistance. bioRxiv : the preprint server for biology. 2026. PMID: 41993544
Bejan CA, Wang M, Venkateswaran S, Bergmann EA, Hiles L, Xu Y, Chandler GS, Brondfield S, Silverstein J, Wright F, de Dios K, Kim DM, Mukherjee E, Krantz MS, Yao L, Johnson DB, Phillips EJ, Balko JM, Mohindra R, Quandt Z. irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets. EBioMedicine. 2026. PMID: 41951517
Reig M, Sanduzzi-Zamparelli M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Díaz A, Llarch N, Iserte G, Mollà M, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal A, Vogel A, Yanagihara TK, Ayuso C, Torres F, Bruix J. Erratum to 'BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update' [J Hepatol (2026) 631-654]. Journal of hepatology. 2026. PMID: 41936510